Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-24-010184 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
233.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-2.47% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-20.35% · CORE · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
76.78% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
4.34% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.35% · OPTIONAL · VALID
SBC intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.47% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 271.72%
Current 233.15%
Delta -38.57% Capex Intensity Decreased
Previous 0.23%
Current 0.00%
Delta -0.23% Cash Generation Decreased
Previous 14.16%
Current -2.47%
Delta -16.63% Growth Decreased
Previous -19.23%
Current -20.35%
Delta -1.13% Margin Increased
Previous 75.28%
Current 76.78%
Delta 1.50% Profitability Increased
Previous -0.75%
Current 4.34%
Delta 5.09% R And D Intensity Decreased
Previous 9.39%
Current 9.35%
Delta -0.04% Sbc Intensity Increased
Previous -0.96%
Current 3.47%
Delta 4.44% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.